- Featured Product
- KD/KO Validated
CHD2 Polyklonaler Antikörper
CHD2 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Ratte
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 21334-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
21334-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA CHD2 und zeigt Reaktivität mit human, Ratten
| Getestete Reaktivität | human, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | CHD2 fusion protein Ag15429 |
| Vollständiger Name | chromodomain helicase DNA binding protein 2 |
| Berechnetes Molekulargewicht | 1828 aa, 211 kDa |
| Beobachtetes Molekulargewicht | 230-250 kDa |
| GenBank-Zugangsnummer | BC020810 |
| Gene symbol | CHD2 |
| Gene ID (NCBI) | 1106 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Chromodomain helicase DNA binding protein 2 (CHD2), a member of the sucrose nonfermenting (SNF-2) protein family of epigenetic regulators, which use the energy from ATP hydrolysis to change nucleosome positioning, composition and chromatin structure(PMID: 33435571). CHD2 protein plays a critical role in embryonic development, tumor suppression and survival(PMID: 24834135). In addition, CHD2 has been proposed to prevent breast cancer initiation, and CHD2 mutations are associated with chronic lymphocytic leukemia.















